a Modified NTU-HELP Program

This study has been completed.
Sponsor:
Collaborators:
National Health Research Institutes, Taiwan
National Science Council, Taiwan
Information provided by (Responsible Party):
National Taiwan University Hospital
ClinicalTrials.gov Identifier:
NCT01045330
First received: January 8, 2010
Last updated: June 10, 2013
Last verified: May 2013
  Purpose

The aim is to replicate, develop, and pilot test a model of care for the prevention and management of functional decline of older patients during hospitalization.


Condition Intervention
Early Ambulation
Behavioral: a modified NTU-HELP

Study Type: Interventional
Study Design: Allocation: Randomized
Endpoint Classification: Efficacy Study
Intervention Model: Parallel Assignment
Masking: Double Blind (Subject, Investigator, Outcomes Assessor)
Primary Purpose: Supportive Care
Official Title: Effect of the National Taiwan University Hospital Elder Life Program

Further study details as provided by National Taiwan University Hospital:

Primary Outcome Measures:
  • Functional status:Barthel Index. Nutrition Status:Mini-Nutritional Assessment, plaque index, Repetitive Saliva Swallowing Test. Cognitive Status:Chinese Mini-Mental State Examination (MMSE). Color Trails Test(CTT). [ Time Frame: admission (T0) to discharge (T1), two weeks (T2), four weeks (T3), and 6 weeks post surgery (T4) ] [ Designated as safety issue: No ]

Enrollment: 304
Study Start Date: August 2009
Study Completion Date: November 2012
Primary Completion Date: November 2012 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
No Intervention: Usual Care Group
Usual care consists of standard hospital services provided by physicians, nurses, and support staff (e.g., physical therapist, dietitian) in the general surgery units.
Experimental: Experimental Group
The intervention consisted of a daily inpatient care protocol on three core intervention protocols on top of hospital routine care.
Behavioral: a modified NTU-HELP
The intervention consists of a daily inpatient care protocol on three core intervention protocols on top of hospital routine care.

Detailed Description:

to develop an intervention protocol that achieves clinical development objectives in a scientifically rigorous and time efficient manner.

  Eligibility

Ages Eligible for Study:   65 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • Age 65 year and older
  • Length of Stay is over 6 days
  • Able to communicate verbally or in writing

Exclusion Criteria:

  • Coma
  • Mechanism ventilation
  • Aphasia, if communication ability is severely impaired
  • Terminal condition with comfort care only, death imminent
  • Combative or dangerous behavior
  • Severe psychotic disorder that prevents patient from participating in interventions
  • Severe dementia (e.g. unable to communicate; MMSE=0). For patients with severe impairment (e.g. MMSE<10), decision to enroll will be made on a case-by-case basis depending on their ability to participate in intervention.
  • Respiratory isolation (e.g. tuberculosis). Patients on contact isolation (e.g. vancomycin-resistant enterococcus) or droplet precautions will be enrolled.
  • Discharge firmly anticipated within 6 days of admission. Enroll if discharge date unsure
  • Refusal by patient or family member.
  • Others. Reason to be well documented.
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT01045330

Locations
Taiwan
National Taiwan Unversity Hospital
Taipei, Taiwan, 110
Sponsors and Collaborators
National Taiwan University Hospital
National Health Research Institutes, Taiwan
National Science Council, Taiwan
Investigators
Principal Investigator: Cheryl Chai-Hui Chen, DNSc National Taiwan University
  More Information

No publications provided

Responsible Party: National Taiwan University Hospital
ClinicalTrials.gov Identifier: NCT01045330     History of Changes
Other Study ID Numbers: 200803077R
Study First Received: January 8, 2010
Last Updated: June 10, 2013
Health Authority: Taiwan: Department of Health

ClinicalTrials.gov processed this record on August 01, 2014